The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Trial Details

NCT ID

NCT06368063

Phase

PHASE4

Sponsor

Xi'an Jiaotong University

Status

RECRUITING

Cancer Type

Pancreatic Cancer

Interventions

• Huaier granule
• chemotherapy drugs

Locations (sample)

• Xi'an, Shannxi, China|34.25833,108.92861

Key Eligibility Criteria

• Age range from 18 to 80 years old, regardless of gender;
• Pancreatic cancer was diagnosed by histopathology after radical surgery within 12 weeks before enrollment;
• Did not receive neoadjuvant therapy before surgery and did not receive any adjuvant therapy after surgery;
• ECOG score 0-3 points;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.